Blog
|
Community
|
Infographics
|
Photos
|
Videos
About Us
Annual Letter from Bill Gates
Annual Reports
Contact Us
Fact Sheet
Financials
Guiding Principles
Letter from Bill & Melinda Gates
Leadership
Jobs
Media Inquiries
New Campus
Speeches
Visitor Center
Programs & Partnerships
Global Development Program
Global Health Program
United States Program
Grantee Profiles
What We're Learning
Progress Reports
Research & Evaluations
Our Commitment to Grantees: Strengthening Partnerships
Topics
Topics
Global Health
Diarrhea
Discovery
Family Planning
HIV/AIDS
Malaria
Maternal, Newborn, & Child Health
Neglected Diseases
Nutrition
Pneumonia & Flu
Polio
Tobacco
Tuberculosis
Vaccines
Poverty & Development
Agricultural Development
Family Homelessness (U.S.)
Financial Services for the Poor
Urban Development
Water, Sanitation & Hygiene
Education & Information
College-Ready Education (U.S.)
Early Learning (U.S.)
Libraries (Global)
Libraries (U.S.)
Postsecondary Education (U.S.)
Scholarships
Special Projects
Emergency Response
Empowering Communities
Topics Overview
Regions
Regions
Africa
Asia
Australia/Oceania
Europe
North America
South America
Regions Overview
Grants
Grants
Information for Grant Seekers
Search Awarded Grants
Frequently Asked Questions
Grants Overview
Home
/
Grants
/
PATH
SHARE
SHARE
Digg
Delicious
Facebook
Newsvine
Reddit
StumbleUpon
Twitter
Email
PATH
Date:
August 2003
Purpose:
to advance the development of priority thermostable vaccines
Amount:
$13,580,287
Term:
9 years and 4 months
Topic:
Vaccines
Region Served:
Global
Program:
Global Health
Grantee Location:
Seattle, Washington
Grantee Web site:
http://www.path.org
Press Release:
Read the release
Bookmark & Share: